Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer — Stella

Recruiting

Back to Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Lithuania

Rita Ambraziene, Kaunas

Key details

Phase

Safety & dosing

Sponsor

Lithuanian University of Health Sciences

Enrollment target

~250 participants

Started

June 2015

Primary completion

June 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated May 2022

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov